what tier are glp-1 drugs Mapping the effectiveness and risks of receptor agonists GLP-1 2.0: Where the Next

Sales of antiobesity drugs hit $1.1 billion in the second quarter of 2023.

- **Slow digestion:** Delaying stomach emptying to prevent spikes in sugar levels after meals

Discover proper techniques for current injectable GLP-1 medications and what to know about future transdermal delivery systems.

Numerous analysts have said the GLP-1s are very likely to disrupt certain areas of the MedTech industry, while others say MedTech can live side-by-side with the weight-loss drugs.1 In fact, the impact of GLP-1s is likely to be more nuanced than the blunt conclusions drawn by market watchers, with some companies and segments affected more than others

Sources for Figure 218

Not intended to replace lifestyle habits